Last updated: May 13, 2024
Sponsor: Technische Universität Dresden
Overall Status: Active - Recruiting
Phase
N/A
Condition
Amyotrophic Lateral Sclerosis (Als)
Scar Tissue
Myasthenia Gravis (Chronic Weakness)
Treatment
N/AClinical Study ID
NCT06418646
ALSpsychosoz
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
patients with at least "possible ALS" according to El-Escorial-criteria
at least 18 years old
no impairments of behaviour or mental performance relevant to everyday life thatlimits the ability to make judgments or give consent (e.g. as part of a comorbidFTD)
Exclusion
Exclusion Criteria:
- impairments of behaviour or mental performance relevant to everyday life that limitsthe ability to make judgments or give consent (e.g. as part of a comorbid FTD)
Study Design
Total Participants: 500
Study Start date:
August 01, 2022
Estimated Completion Date:
June 30, 2025
Connect with a study center
University Hospital Carl Gustav Carus at Technische Universität Dresden
Dresden, Saxony 01307
GermanyActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.